AstraZeneca pledges $150 million for production facility in Russia
This article was originally published in Scrip
Executive Summary
AstraZeneca's division in Russia has announced that the company will invest $150 million in the construction of a full-cycle production facility in Vorsino near Kaluga, a city 150 kilometres south-west of Moscow.